Mass Spectrometry is key technology for studying critical molecules and pathways. Defining molecular targets is crucial for the process of drug development.
In our group, we are focused on using proteomics, mass spectrometry and biochemical approaches to understand disease processes.
The group has expertise in proteomics based methodologies and hosts a platform containing a variety of chromatography equipment and mass spectrometers.
Kessler Group Sky Garden London Nov 2018
- For Non-Scientists
- Research Overview
- Mass Spectrometry
- Public Engagement
- Photo Gallery
- Virtual tour of the Kessler Lab
- Former Group Members
Regulation of the endosomal SNX27-retromer by OTULIN
Stangl A. et al, (2019), Nature Communications, 10
Extracellular vesicle integrins act as a nexus for platelet adhesion in cerebral microvessels.
Bagi Z. et al, (2019), Scientific reports, 9
PROTEOMICS REVEALS MOLECULAR WINDOW AND METABOLISM OF NORMOTHERMICALLY PERFUSED HUMAN KIDNEYS
Weissenbacher A. et al, (2019), TRANSPLANT INTERNATIONAL, 32, 26 - 26
Proteomics analysis of the matrisome from MC38 experimental mouse liver metastases.
Yuzhalin AE. et al, (2019), Am J Physiol Gastrointest Liver Physiol
Comprehensive Landscape of Active Deubiquitinating Enzymes Profiled by Advanced Chemoproteomics
(2019), Frontiers in Chemistry